Peripheral cytokine-induced CNS immune activation and effects on mesolimbic dopamine Open Access

Block, Andrew McGowan (2016)

Permanent URL: https://etd.library.emory.edu/concern/etds/9593tv35d?locale=en%5D
Published

Abstract

Peripheral administration of inflammatory cytokines such as interferon alpha (IFNα) has been shown to reliably induce depressive behaviors in humans and non-human primates (NHPs) that are related to reduced motivation and anhedonia. Peripheral administration of inflammatory cytokines and cytokine-inducers (e.g. endotoxin) has also been shown to reduce neural activation of the ventral striatum to hedonic reward in humans. Our previous work in NHPs suggests that the effects of peripheral inflammation on reward circuitry and behavior may by due to decreased availability and release of dopamine. However, the immunologic and neurobiologic mechanisms by which peripheral cytokines affect the dopamine system is currently unknown. Herein immune activation was assessed in relation to effects on the dopamine system in the ventral and dorsal striatum in post-mortem brain tissue from rhesus monkeys (aged 10-14 yrs) exposed to chronic IFNα (20 MIU/m2 s.c. for 4 weeks, n=7) compared to saline control (n=4). Significantly less tissue content of dopamine was observed in the nucleus accumbens (p=0.004) and putamen (p=0.009) of IFNα-treated animals. Whole-gene expression analysis revealed induction of limited immune signaling pathways by IFNα in association with activation of immune cells primarily in vascular and meningeal compartments in or near putamen. Whole genome and targeted analysis also revealed alterations in genes related to dopamine neurotransmission and receptor signaling. These results support our previous findings of decreased striatal dopamine release in IFNα-treated monkeys, and indicate that effects of peripheral IFNα on brain dopamine are likely driven by peripheral immune cells trafficking to the CNS.

Table of Contents

INTRODUCTION. 2

METHODS. 6

SUBJECTS AND BRAIN TISSUE COLLECTION. 6

HPLC FOR TISSUE DOPAMINE CONCENTRATIONS. 6

GENE EXPRESSION. 7

IMMUNOFLUORESCENCE. 8

STATISTICS. 9

RESULTS. 10

DECREASED TISSUE CONTENT OF DOPAMINE IN NUCLEUS ACUMBENS AND PUTAMEN. 10

CHANGES IN INFLAMMATORY AND NEUROTRANSMITTER-RELATED GENE EXPRESSION, WHOLE GENOME ANALYSIS. .11

DECREASED EXPRESSION OF DOPAMINE-RELATED GENES, TARGETED ANALYSIS. 13

INCREASED ACTIVATED IMMUNE CELLS IN AND AROUND PERIVASCULAR AND MENINGEAL SPACES. 14

DISCUSSION. 16

TABLES AND FIGURES. 20

TABLE 1. 20

TABLE 2. 22

FIGURE 1. 26

FIGURE 2. 27

FIGURE 3. 27

FIGURE 4. 28

FIGURE 5. .29

REFERENCES. 30

SUPPLEMENTAL MATERIALS. 36

FIGURE S1. 36

FIGURE S2. 37

FIGURE S3. 37

TABLE S1. 38

TABLE S2. 92

About this Honors Thesis

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Degree
Submission
Language
  • English
Research Field
Keyword
Committee Chair / Thesis Advisor
Committee Members
Last modified

Primary PDF

Supplemental Files